Lateral flow tests have all the hallmarks of a quality diagnostic test.
Fast-acting and versatile, they can be used at the point of care with or without a reader, meaning that they’re easy to use, require little training and are easily deployed in any location.
This extraordinary technology is an area where Mologic are continuing to make huge advances.
Speaking with Paul Davis, Co-founder and Chief Scientific Officer at Mologic, it was fascinating to hear what he had to say on the next steps for lateral flow. How could we improve this beautifully simple technology?
.jpg)
Diagnostics still has a crucial role to play in combating COVID-19 and, with new funding, a lot of exciting plans too. To find out more, I spoke to Jonathan O’Halloran, who is CEO at QuantuMDx.
What do you want from diagnostics? Before COVID-19, this wouldn’t have been a question at the forefront of so many peoples' minds. However, now it is and consumers are demanding changes to the industry.
.jpg)
There’s optimism throughout all the markets we serve and to celebrate this we asked our CM Life Science team what they think we can expect from the year ahead in life sciences. Here's what they said...
